ZeroAvia, Edmonton Airport partner to develop hydrogen infrastructure
ZeroAvia has partnered with Edmonton International Airport to work on hydrogen infrastructure development for zero-emission flights.
Stay updated with breaking news from Arnab Chatterjee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ZeroAvia has partnered with Edmonton International Airport to work on hydrogen infrastructure development for zero-emission flights.
/PRNewswire/ -- ZeroAvia, the leader in developing zero-emission solutions for commercial aviation, today announced a collaboration with Edmonton International...
ZeroAvia and Edmonton International Airport (EIA) in Canada have today (July 21) announced a collaboration to bring hydrogen-electric flight to the country.
Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.
A major new antiviral drug development center led by Scripps Research in La Jolla to prime for the next pandemic is getting a $67 million award over three years from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, with potential renewal for two additional years.